|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/535 | |
| A61K 31/50 | |||
| A61K 31/445 | |||
| A61K 31/44 | |||
| A61K 31/40 | |||
| A61K 31/34 | |||
| A61K 31/17 |
| (11) | Number of the document | 2298311 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10180762.6 |
| Date of filing the European patent application | 2000-01-13 | |
| (97) | Date of publication of the European application | 2011-03-23 |
| (45) | Date of publication and mention of the grant of the patent | 2012-05-09 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 115878 P | 1999-01-13 | US | |
| 257265 | 1999-02-25 | US | |
| 425229 | 1999-10-22 | US |
| (72) |
Riedl, Bernd, DE
Dumas, Jacques, US
Khire, Uday, US
Lowinger, Timothy B., US
Scott, William J., US
Smith, Roger A., US
Wood, Jill E., US
Monahan, Mary-Katherine, US
Natero, Reina, US
Renick, Joel, US
Sibley, Robert N., US
|
| (73) |
Bayer HealthCare LLC,
555 White Plains Road, Tarrytown, NY 10591,
US
|
| (54) | w-Carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors |
| w-Carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors |